TrialCancer medicine2013

Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab.

Timothy J Price et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.